학술논문
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation
Document Type
Article
Author
Introna, Martino; Lussana, Federico; Algarotti, Alessandra; Gotti, Elisa; Valgardsdottir, Rut; Micò, Caterina; Grassi, Anna; Pavoni, Chiara; Ferrari, Maria Luisa; Delaini, Federica; Todisco, Elisabetta; Cavattoni, Irene; Deola, Sara; Biagi, Ettore; Balduzzi, Adriana; Rovelli, Attilio; Parma, Matteo; Napolitano, Sara; Sgroi, Giusy; Marrocco, Emanuela; Perseghin, Paolo; Belotti, Daniela; Cabiati, Benedetta; Gaipa, Giuseppe; Golay, Josée; Biondi, Andrea; Rambaldi, Alessandro
Source
Biology of Blood and Marrow Transplantation (Science Direct); 20240101, Issue: Preprints
Subject
Language
ISSN
10838791; 15236536
Abstract
•Sequential infusion of DLI and CIK cells appears to be safe with a low incidence of GVHD.•Donor-derived DLI + CIK cells can be safely administered in relapsed patients.•Passive adoptive immunotherapy T (CIK) cells are the object of this phase II trial.